Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by elgin1on May 19, 2020 11:52am
101 Views
Post# 31046274

RE:RE:RE:RE:RE:RE:RE:Results !

RE:RE:RE:RE:RE:RE:RE:Results ! 
BioTeck wrote: Elgin, you are wasting your time. I am quite familiar with the science. What I'm saying is that this isn't NEW news. It is nearly 2 years old. There is nothing in this news that wasn't released 2 years ago.



Bioteck if if you are familiar with the science , which I truly believe you are, then this is an update with more scientific data that is published to corroborate the initial news. If you understand science , then you have to have studies that show statistical significance and that are peer reviewed. 

There is is nothing wrong with them presenting their data on Hemophilia . It creates longterm value for an acquisition by pharma in the future. 


i am waiting for the real catalyst . More data on additional patients with Fda trial on diabetes and any detail progress with pharma collaboration. 

Bioteck shouldnt you be working since you are self employed instead of spending all your time critiquing Sva’s potential downfalls as an investment ? 
Bullboard Posts